We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-21.98%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
$0
Cap. Flow
-$63.6K
Cap. Flow %
-0%
Top 10 Hldgs %
13.08%
Holding
3,173
New
Increased
3
Reduced
4
Closed

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAL
1676
DELISTED
Salisbury Bancorp, Inc.
SAL
$22K ﹤0.01%
1,000
CATM
1677
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$22K ﹤0.01%
534
HCBC
1678
DELISTED
HIGH COUNTRY BANCORP INC
HCBC
$22K ﹤0.01%
500
CEO
1679
DELISTED
CNOOC Limited
CEO
$22K ﹤0.01%
133
ALB icon
1680
Albemarle
ALB
$13.9B
$21K ﹤0.01%
291
ALNY icon
1681
Alnylam Pharmaceuticals
ALNY
$27.5B
$21K ﹤0.01%
185
AROC icon
1682
Archrock
AROC
$6.27B
$21K ﹤0.01%
2,108
BLMN icon
1683
Bloomin' Brands
BLMN
$741M
$21K ﹤0.01%
995
EPAC icon
1684
Enerpac Tool Group
EPAC
$1.83B
$21K ﹤0.01%
816
EWH icon
1685
iShares MSCI Hong Kong ETF
EWH
$1.24B
$21K ﹤0.01%
866
FUL icon
1686
H.B. Fuller
FUL
$2.97B
$21K ﹤0.01%
418
IUSG icon
1687
iShares Core S&P US Growth ETF
IUSG
$31.7B
$21K ﹤0.01%
325
JBGS
1688
JBG SMITH
JBGS
$818M
$21K ﹤0.01%
550
KNOP icon
1689
KNOT Offshore Partners
KNOP
$372M
$21K ﹤0.01%
1,100
PSCH icon
1690
Invesco S&P SmallCap Health Care ETF
PSCH
$163M
$21K ﹤0.01%
489
RGNX icon
1691
Regenxbio
RGNX
$620M
$21K ﹤0.01%
545
RMBS icon
1692
Rambus
RMBS
$9.87B
$21K ﹤0.01%
1,578
RYN icon
1693
Rayonier
RYN
$6.55B
$21K ﹤0.01%
716
SBRA icon
1694
Sabra Healthcare REIT
SBRA
$5.34B
$21K ﹤0.01%
985
STM icon
1695
STMicroelectronics
STM
$46.7B
$21K ﹤0.01%
783
WING icon
1696
Wingstop
WING
$3.53B
$21K ﹤0.01%
252
KAMN
1697
DELISTED
Kaman Corp
KAMN
$21K ﹤0.01%
329
POLY
1698
DELISTED
Plantronics, Inc.
POLY
$21K ﹤0.01%
771
TECD
1699
DELISTED
Tech Data Corp
TECD
$21K ﹤0.01%
151
AA icon
1700
Alcoa
AA
$11.9B
$20K ﹤0.01%
976

Similar funds

Glenmede Trust's Q1 2020 Portfolio in Review

As of Q1 2020, Glenmede Trust held 3,173 positions worth $21.9B, unchanged from the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Trading was light in Q1 2020: portfolio turnover was 0%. Glenmede Trust opened no new positions and made no exits, leaving the 3,173-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, unchanged from a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust added most to Interpace Biosciences, Inc. Common Stock in Q1 2020, an estimated $51.9K increase.
  • Glenmede Trust's biggest Q1 2020 reduction was Brookfield Infrastructure Partners, cutting an estimated $78.8K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q1 2020.
  • Glenmede Trust opened 0 new positions and closed 0 in Q1 2020.
  • Glenmede Trust's portfolio value was unchanged quarter-over-quarter at $21.9B.

Based on Glenmede Trust's 13F filing for Q1 2020, filed 20 May 2020.